rapid weight gain after semaglutide Trajectory of regain cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regression Live updates: Ozempic and Wegovy

10.1016/j.ijpharm.2021.121317

Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice

When to Reassess Protocol Signs of Positive Response Improved energy consistency and reduced afternoon fatigue (week 1-4) Faster healing of minor cuts and skin blemishes (week 2-4) Visible skin tone evening reduced dullness, brighter complexion (week 4-8) Declining AST/ALT on bloodwork (week 4-8) Reduced hs-CRP indicating lower systemic inflammation (week 4-8) Nail quality improvements reduced brittleness, improved growth (week 4-8) Signs to Reassess No subjective or objective changes after 8 weeks evaluate delivery route first

HCP Live (2024)

Semaglutide should not be used in individuals with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)